← All Leonardo Drs, INC filings

Leonardo Drs, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
DRS
Leonardo Drs, INC
DEF: Leonardo DRS Announces Leadership Transition and Annual Meeting Details
Leonardo DRS, Inc. has announced a planned leadership transition with William J. Lynn III retiring as Chairman and CEO, succeeded by John A. Baylouny, and Frances F. Townsend elected as Chair of the Board, alongside details for the upcoming virtual Annual Meeting of Stockholders.
NASDAQ
DRS
Leonardo Drs, INC
DEFA14A: Leonardo DRS, Inc. Files Definitive Proxy Statement
Leonardo DRS, Inc. files its definitive proxy statement with the SEC.
NASDAQ
DRS
Leonardo Drs, INC
DEF: Leonardo DRS Sets Date for Virtual Annual Meeting, Proposes Charter Amendment
Leonardo DRS will hold its annual meeting virtually on June 4, 2025, and is seeking stockholder approval for several proposals, including a charter amendment to remove supermajority voting requirements.
NASDAQ
DRS
Leonardo Drs, INC
DEFA14A: Leonardo DRS Clarifies Voting Requirements for Upcoming Annual Meeting
Leonardo DRS issues a supplement to its proxy statement clarifying the voting requirements for Proposals 4 and 5 at the upcoming annual meeting on May 15, 2024.
NASDAQ
DRS
Leonardo Drs, INC
DEFA14A: Leonardo DRS, Inc. Files Definitive Proxy Statement
Leonardo DRS, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
DRS
Leonardo Drs, INC
DEF 14A: Leonardo DRS Sets Date for Annual Stockholders Meeting, Outlines Key Proposals
Leonardo DRS announces its annual stockholders meeting to be held virtually on May 15, 2024, outlining proposals for director elections, executive compensation, auditor ratification, and equity plan approvals.